Phibro Animal Health Stock Performance
| PAHC Stock | USD 25.12 0.37 1.49% |
On a scale of 0 to 100, Phibro Animal holds a performance score of 7. The company holds a Beta of 1.35, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Phibro Animal will likely underperform. Please check Phibro Animal's jensen alpha, potential upside, accumulation distribution, as well as the relationship between the treynor ratio and expected short fall , to make a quick decision on whether Phibro Animal's historical price patterns will revert.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Phibro Animal Health are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak technical indicators, Phibro Animal exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 1.49 | Five Day Return 4.02 | Year To Date Return 21.18 | Ten Year Return (30.61) | All Time Return 47.76 |
Forward Dividend Yield 0.0191 | Payout Ratio | Forward Dividend Rate 0.48 | Dividend Date 2025-06-25 | Ex Dividend Date 2025-06-04 |
1 | 3 Reasons Growth Investors Will Love Phibro | 05/12/2025 |
2 | Woodline Partners LP Invests 12.34 Million in Patterson Companies, Inc. | 05/22/2025 |
3 | Illumina Introduces a New AI algorithm PromoterAI Stock to Gain | 05/30/2025 |
4 | Bruker Stock Set to Gain From Acquisition of Austrias biocrates | 06/10/2025 |
5 | In NCLA Amicus Win, District Court Topples Kansas Dog Kennel No-Warrant Inspection Regime | 06/12/2025 |
6 | Are Investors Undervaluing Phibro Animal Health Right Now | 06/13/2025 |
7 | Phibro Animal Health Rating Upgraded by Analyst PAHC Stock News | 06/16/2025 |
8 | DGX Stock Up on New Blood Test Development Deal With MD Anderson | 06/17/2025 |
9 | BNP Paribas Upgrades Phibro Animal Health to Hold | 06/18/2025 |
10 | Is Phibro a Solid Growth Stock 3 Reasons to Think Yes | 06/23/2025 |
| Phibro Animal dividend paid on 25th of June 2025 | 06/25/2025 |
| Begin Period Cash Flow | 41.3 M |
Phibro Animal Relative Risk vs. Return Landscape
If you would invest 2,125 in Phibro Animal Health on March 29, 2025 and sell it today you would earn a total of 387.00 from holding Phibro Animal Health or generate 18.21% return on investment over 90 days. Phibro Animal Health is currently generating 0.3305% in daily expected returns and assumes 3.5394% risk (volatility on return distribution) over the 90 days horizon. In different words, 31% of stocks are less volatile than Phibro, and 94% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Phibro Animal Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Phibro Animal's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Phibro Animal Health, and traders can use it to determine the average amount a Phibro Animal's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0934
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PAHC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.54 actual daily | 31 69% of assets are more volatile |
Expected Return
| 0.33 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average Phibro Animal is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Phibro Animal by adding it to a well-diversified portfolio.
Phibro Animal Fundamentals Growth
Phibro Stock prices reflect investors' perceptions of the future prospects and financial health of Phibro Animal, and Phibro Animal fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Phibro Stock performance.
| Return On Equity | 0.12 | ||||
| Return On Asset | 0.0626 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 1.7 B | ||||
| Shares Outstanding | 20.37 M | ||||
| Price To Earning | 11.39 X | ||||
| Price To Book | 3.77 X | ||||
| Price To Sales | 0.84 X | ||||
| Revenue | 1.02 B | ||||
| Gross Profit | 384.22 M | ||||
| EBITDA | 84.61 M | ||||
| Net Income | 2.42 M | ||||
| Cash And Equivalents | 98.67 M | ||||
| Cash Per Share | 2.44 X | ||||
| Total Debt | 525.46 M | ||||
| Debt To Equity | 1.79 % | ||||
| Current Ratio | 2.97 X | ||||
| Book Value Per Share | 6.56 X | ||||
| Cash Flow From Operations | 87.59 M | ||||
| Earnings Per Share | 0.78 X | ||||
| Market Capitalization | 1 B | ||||
| Total Asset | 982.18 M | ||||
| Retained Earnings | 243.89 M | ||||
| Working Capital | 396.85 M | ||||
| Current Asset | 342.83 M | ||||
| Current Liabilities | 108.78 M | ||||
About Phibro Animal Performance
By analyzing Phibro Animal's fundamental ratios, stakeholders can gain valuable insights into Phibro Animal's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Phibro Animal has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Phibro Animal has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 123.98 | 94.65 | |
| Return On Capital Employed | 0.08 | 0.14 | |
| Return On Equity | 0.01 | 0.01 |
Things to note about Phibro Animal Health performance evaluation
Checking the ongoing alerts about Phibro Animal for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Phibro Animal Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Phibro Animal Health had very high historical volatility over the last 90 days | |
| Over 99.0% of the company shares are owned by institutional investors | |
| On 25th of June 2025 Phibro Animal paid $ 0.12 per share dividend to its current shareholders | |
| Latest headline from gurufocus.com: Phibro Animal Health Price Target Raised by Morgan Stanley PAHC Stock News |
- Analyzing Phibro Animal's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Phibro Animal's stock is overvalued or undervalued compared to its peers.
- Examining Phibro Animal's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Phibro Animal's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Phibro Animal's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Phibro Animal's stock. These opinions can provide insight into Phibro Animal's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Phibro Stock analysis
When running Phibro Animal's price analysis, check to measure Phibro Animal's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phibro Animal is operating at the current time. Most of Phibro Animal's value examination focuses on studying past and present price action to predict the probability of Phibro Animal's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phibro Animal's price. Additionally, you may evaluate how the addition of Phibro Animal to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |